Blog · Vestibular← The news desk

✦ The Dispatch

Gepant drugs show promise for treating vestibular migraine symptoms

A dispatch from Hearing Practitioner Australia — filed

Woman with braided hair in a bun sitting on a sofa, head in hands, appearing distressed or in pain, in a light-toned room.
✦ PlateWoman with braided hair in a bun sitting on a sofa, head in hands, appearing distressed or in pain, in a light-toned room.

Vestibular migraine is the most common cause of recurrent spontaneous vertigo, affecting balance and causing symptoms such as dizziness, vertigo, motion sensitivity and nausea. Image: Andrey Popov/stock.adobe.com. A class of migraine medications known as gepants may offer a new treatment option for people with vestibular migraine, according to a small study....

Clinical Takeaway

No actionable change at this time — the evidence for gepants in vestibular migraine is preliminary and based on blog-level trade reporting; await peer-reviewed clinical trial data before altering management.

Why It Matters

Vestibular migraine is frequently encountered in audiology and vestibular clinics, so emerging pharmacological options are worth monitoring as the evidence matures.

Key Points
  1. 01Gepant-class drugs (CGRP receptor antagonists used for migraine) are being explored for vestibular migraine.
  2. 02Vestibular migraine is cited as the most common cause of recurrent spontaneous vertigo.
  3. 03Key symptoms include dizziness, motion sensitivity, and nausea — not always headache.
  4. 04Report is trade-blog level; no primary study data or trial results are cited.
  5. 05Audiologists and vestibular specialists should watch for forthcoming peer-reviewed evidence.
Claims & Evidence

Vestibular migraine is the most common cause of recurrent spontaneous vertigo.

unknownpartially supported

Gepant-class medications show potential as a treatment for vestibular migraine symptoms.

unknownunclear
Related stories